the first tests patients new form cancer treatment developed british company shown promising results data published yesterday show british biotechnologys drug batimastat performed well enough 15 patients trial investigators give additional doses patients professor john smyth imperial cancer research funds medical oncology unit edinburghs western general hospital said encouraged results trial suggested drug may effective treatment ovarian cancer it shown significant side effects batimastat works acting enzymes destroy tissue surrounding cancer cells if drug well next two years clinical trials could used treatment variety cancers including breast lung colorectal prostate even patients close death mr james noble finance director british biotechnology said 650000 people died latestage cancers year europe us the second phase clinical trials starts next month third phase needed applications approval worlds health regulatory bodies begin later year cancer drugs often receive priority treatment regulatory bodies many patients respond well enough existing treatments batimastat works acting enzymes destroy tissue surrounding cancer cells by breaking tissues cancer grow spread british biotechnology shares rose 5p 450p yesterday